Suppr超能文献

使用即时检验法建立犬猫血氨推断参考范围

Establishment of an Inferred Reference Range for Blood Ammonia in Dogs and Cats Using a Point-of-Care Assay.

作者信息

Specchia Giulia, Seidel Emily Hannah Doran, Dye Charlotte

机构信息

Pride Veterinary Referrals, IVC Evidensia, Riverside Rd, Derby DE24 8HX, UK.

Creature Comforts Chiswick, 376 Chiswick High Rd., Chiswick, London W4 5TF, UK.

出版信息

Vet Sci. 2025 Jun 17;12(6):596. doi: 10.3390/vetsci12060596.

Abstract

Point-of-care (POC) tests for blood ammonia (BA) measurement have not been well evaluated in veterinary species. This cross-sectional study sought to establish an inferred reference interval for BA using a POC analyser in dogs and cats. Blood ammonia was measured in 175 dogs and 63 cats for which relevant clinical history and laboratory data was available. Reference values were inferred based on comparisons between patients with and without disease pathologies reported to cause BA elevation. Descriptive statistics, Pearson Chi, and Mann-Whitney U testing were used to assess for associations between clinical parameters and BA concentration. Seventy-one percent (124/175) of dogs and forty-six percent (29/63) of cats had undetectable BA. Following the exclusion of dogs with potential causes of hyperammonaemia, all remaining dogs had BA < 30 µg/dL. With one exception, all dogs with BA > 30 µg/dL had liver disease. All dogs with a clinical suspicion of hepatic encephalopathy (HE) had BA > 40 µg/dL. Following the exclusion of cats with potential causes of hyperammonaemia, all remaining cats had BA < 25 µg/dL. Only 50% of cats with BA > 25 µg/dL had liver disease. All cats with a clinical suspicion of HE had BA > 30 µg/dL. Based on this study population, BA < 30 µg/dL and <25 µg/dL should be considered normal in dogs and cats, respectively. Additionally, dogs with BA > 30 µg/dL are likely to have liver disease, while cats with BA > 25 µg/dL appear to exhibit a wider variety of disease pathologies.

摘要

用于测量血氨(BA)的即时检验(POC)在兽医物种中尚未得到充分评估。这项横断面研究旨在使用POC分析仪为犬猫建立BA的推断参考区间。对175只犬和63只猫进行了血氨测量,并获取了相关临床病史和实验室数据。根据报告可导致BA升高的疾病病理状态的有无,对患者进行比较,从而推断参考值。使用描述性统计、Pearson卡方检验和Mann-Whitney U检验来评估临床参数与BA浓度之间的关联。71%(124/175)的犬和46%(29/63)的猫BA检测不到。排除有高氨血症潜在病因的犬后,所有剩余犬的BA均<30µg/dL。除一例例外,所有BA>30µg/dL的犬均患有肝病。所有临床怀疑患有肝性脑病(HE)的犬BA均>40µg/dL。排除有高氨血症潜在病因的猫后,所有剩余猫的BA均<25µg/dL。BA>25µg/dL的猫中只有50%患有肝病。所有临床怀疑患有HE的猫BA均>30µg/dL。基于该研究群体,犬和猫的BA分别<30µg/dL和<25µg/dL应被视为正常。此外,BA>30µg/dL的犬可能患有肝病,而BA>25µg/dL的猫似乎表现出更多样化的疾病病理状态。

相似文献

2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.
Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD009276. doi: 10.1002/14651858.CD009276.pub2.
5
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.

本文引用的文献

1
Hyperammonaemia: review of the pathophysiology, aetiology and investigation.
Pathology. 2024 Oct;56(6):763-772. doi: 10.1016/j.pathol.2024.06.002. Epub 2024 Jul 25.
3
Current approaches to hepatic encephalopathy.
Ann Hepatol. 2022 Nov-Dec;27(6):100757. doi: 10.1016/j.aohep.2022.100757. Epub 2022 Sep 14.
5
Sex differences in renal ammonia metabolism.
Am J Physiol Renal Physiol. 2021 Jan 1;320(1):F55-F60. doi: 10.1152/ajprenal.00531.2020. Epub 2020 Dec 14.
6
Hyperammonemia in azotemic cats.
J Feline Med Surg. 2021 Aug;23(8):700-707. doi: 10.1177/1098612X20972039. Epub 2020 Nov 20.
7
Transient hyperammonaemia following epileptic seizures in cats.
J Feline Med Surg. 2021 Jun;23(6):534-539. doi: 10.1177/1098612X20962747. Epub 2020 Oct 9.
9
Clinical manifestations and management of fatty acid oxidation disorders.
Rev Endocr Metab Disord. 2020 Dec;21(4):479-493. doi: 10.1007/s11154-020-09568-3.
10
Severe hyperammonemia from intense skeletal muscle activity: A rare case report and literature review.
Medicine (Baltimore). 2019 Nov;98(47):e17981. doi: 10.1097/MD.0000000000017981.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验